tirzepatide and menopause Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 New research from a Mayo

What to do Its important to remember: never stop medication on your own

Shotsy also offers tirzepatide tracking but requires a $49.99/year subscription for medication level charts

The retatrutide versus semaglutide comparison shows a clear advantage for the triple agonist, and the retatrutide versus Ozempic data tells a similar story

So researchers looked at the medical records of more than 3,000 people with hormone receptor-positive DCIS on hormonal therapy and GLP-1s, as well as an equal number of people with hormone receptor-positive DCIS who were not taking GLP-1s

It can feel like being a little tired, a little shaky, maybe slightly foggy